256 related articles for article (PubMed ID: 18425131)
21. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
22. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
Kotner J; Tarleton R
Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
[TBL] [Abstract][Full Text] [Related]
23. Limited Foxp3
Araujo Furlan CL; Tosello Boari J; Rodriguez C; Canale FP; Fiocca Vernengo F; Boccardo S; Beccaria CG; Adoue V; Joffre O; Gruppi A; Montes CL; Acosta Rodriguez EV
Front Immunol; 2018; 9():2555. PubMed ID: 30455700
[TBL] [Abstract][Full Text] [Related]
24. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
Alvarez MG; Bertocchi GL; Cooley G; Albareda MC; Viotti R; Perez-Mazliah DE; Lococo B; Castro Eiro M; Laucella SA; Tarleton RL
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004657. PubMed ID: 27128444
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease.
Olivieri BP; Molina JT; de Castro SL; Pereira MC; Calvet CM; Urbina JA; Araújo-Jorge TC
Int J Antimicrob Agents; 2010 Jul; 36(1):79-83. PubMed ID: 20452188
[TBL] [Abstract][Full Text] [Related]
26. Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules.
Grisotto MG; D'Império Lima MR; Marinho CR; Tadokoro CE; Abrahamsohn IA; Alvarez JM
Immunology; 2001 Feb; 102(2):209-17. PubMed ID: 11260326
[TBL] [Abstract][Full Text] [Related]
27. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
Front Immunol; 2018; 9():997. PubMed ID: 29867974
[TBL] [Abstract][Full Text] [Related]
28. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
29. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8.
Rottenberg ME; Riarte A; Sporrong L; Altcheh J; Petray P; Ruiz AM; Wigzell H; Orn A
Immunol Lett; 1995 Feb; 45(1-2):53-60. PubMed ID: 7622189
[TBL] [Abstract][Full Text] [Related]
30. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
[TBL] [Abstract][Full Text] [Related]
31. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Jones K; Versteeg L; Damania A; Keegan B; Kendricks A; Pollet J; Cruz-Chan JV; Gusovsky F; Hotez PJ; Bottazzi ME
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311242
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of T Cells Repertoire During Trypanosoma cruzi Infection and its Post-Treatment Modulation.
Egui A; Lasso P; Pérez-Antón E; Thomas MC; López MC
Curr Med Chem; 2019; 26(36):6519-6543. PubMed ID: 30381063
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.
Albareda MC; Natale MA; Cesar GL; Castro Eiro MD; Alvarez MG; Laucella SA
Methods Mol Biol; 2019; 1955():339-348. PubMed ID: 30868539
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
[TBL] [Abstract][Full Text] [Related]
35. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
Wrightsman RA; Luhrs KA; Fouts D; Manning JE
Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
[TBL] [Abstract][Full Text] [Related]
36. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
37. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance.
Tzelepis F; de Alencar BC; Penido ML; Claser C; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
J Immunol; 2008 Feb; 180(3):1737-48. PubMed ID: 18209071
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH; Sette A; Postan M; Tarleton RL
PLoS Pathog; 2006 Aug; 2(8):e77. PubMed ID: 16879036
[TBL] [Abstract][Full Text] [Related]
39. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
Dhiman M; Garg NJ
PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
